What question did this study set out to answer?

Evaluate U.S. mortality trends related to neurodegenerative diseases from 1999 to 2020.

June 13, 2026Neurology

National Mortality Trend in Neurodegenerative Diseases involving Alzheimer’s, Parkinson’s, and Basal Ganglia Degeneration: A CDC WONDER Analysis, 1999–2020. (P7-20.007)

View Full Paper

Ask AI

Bookmark

Evaluate U.S. mortality trends related to neurodegenerative diseases from 1999 to 2020.
Analysis of mortality data using CDC WONDER database
Focus on Alzheimer's, Parkinson's, and basal ganglia degeneration
Comparison of trends over the two-decade span
Identified significant trends in mortality rates for Alzheimer's and Parkinson's diseases
Showed variations in mortality rates over the years
Insights suggest changes in health policy and public health interventions may be needed

Analysis uncovers mortality trends in neurodegenerative diseases in the U.S., highlighting significant insights.

This study aims to evaluate U.S. mortality trends in Alzheimer’s, Parkinson’s, and basal ganglia degeneration from 1999 to 2020.

No takes yet. Share an insight, caveat, or question.

Ali et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Analysis uncovers mortality trends in neurodegenerative diseases in the U.S., highlighting significant insights.

This study aims to evaluate U.S. mortality trends in Alzheimer’s, Parkinson’s, and basal ganglia degeneration from 1999 to 2020.